Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 46Neoplasms 32Lung Neoplasms 25Colorectal Neoplasms 22Uterine Cervical Neoplasms 14Prostatic Neoplasms 13Motor Activity 11Colonic Neoplasms 10Anxiety Disorders 9Rectal Neoplasms 8Pancreatic Neoplasms 8Obesity 8Carcinoma, Non-Small-Cell Lung 8Hematologic Neoplasms 7Endometrial Neoplasms 7Depression 7Ovarian Neoplasms 6Lymphoma 6Breast Carcinoma In Situ 6Vulvar Neoplasms 5Urinary Bladder Neoplasms 5Neoplasm Metastasis 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4Smoking Cessation 4Pain 4Melanoma 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4

Interventions

Tobacco Products 1Standard of Care 1Methods 1Gain of Function Mutation 1Costs and Cost Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Tobacco Smoking × Methods × Clear all
NCT06945120 2026-03-13

ACT Lung Health Intervention: Phase Two

Dana-Farber Cancer Institute

Phase NA Recruiting
50 enrolled

Cigarette Smoking, Tobacco Smoking, Smoking, Smoking Cessation, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡